What's breaking now, across thousands of outlets.
Trial participants mostly kept their weight down after switching from a weekly shot to less frequent dosing — findings that could strengthen Viking’s “competitive positioning,” one analyst wrote.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
(MedPage Today) -- After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new…
Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.
For starters, they need to take the same approach they did to vaping The post Peptides Are Spreading on Social Media. Here’s How Platforms Can Better Protect Public Health appeared first on Nautilus .
Adam Bryce tells us why understanding CAF morphology could bring discovery research to bear on clinical decision making for pancreatic cancer The post Form follows function: decoding pancreatic cancer…
"It’s time for us to manufacture our own vaccines," Jean Kaseya said at Semafor’s The Next 3 Billion.
In a social media post, the Health Minister responded to a report published by The Hindu on the shortage of surfactants for the past few months
